Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation and Validation of a Monitoring, Screening and Management Strategy for Conductive Disorders After TAVR (EVATAVI)

NCT05417464 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05417464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05417464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation and Validation of a Monitoring, Screening and Management Strategy for Conductive Disorders After TAVR (EVATAVI)
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
February 21, 2023
Completion date
October 4, 2024
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

valvular heart disease